The ACREME team took some well-earned time out in Bangkok to enjoy a relaxed dinner during the APMEN Joint Working Group Meeting. Sometimes the best collaboration happens over good food and even better company 🤝🌏 #Collaboration #GlobalHealth #Bangkok #Malaria #Network #GlobalCollaboration

Photos from the APMEN Joint Working Group meeting in Bangkok 🦟Great to see @kthriemer.bsky.social & Stephan Karl sharing their insights and contributing to important discussions on malaria elimination across the region. 📷 : Win Han Oo #MalariaElimination #GlobalHealth #EndMalaria

Professor Leanne Robinson of @burnetinstitute.bsky.social recently spoke with Madlen Luckner (Nature Communications), reflecting on her work toward malaria elimination and the evolving challenges and opportunities in the field. Read the full interview: www.nature.com/articles/s41...

This study aimed to evaluate the 7-day low-dose primaquine regimen in G6PD-normal patients with uncomplicated P. vivax and/or P. falciparum malaria in the pre-elimination context of Nepal. 🔗 onlinelibrary.wiley.com/doi/10.1111/...

ACREME Investigators will attend the upcoming APMEN Joint Working Groups Meeting in Bangkok, next week ✈️Held under the theme “One Network, Integrated Solutions: Driving a Malaria-Free Asia Pacific,” the meeting will bring together national malaria programs and key partners.

Join ACREME Investigator, Prof Alyssa Barry as World Malaria Day approaches, for a preview of research featured at the upcoming World Malaria Day Seminar 2026. 📅 Tuesday, 21 April at 10am 📍 Lecture Theatre, Health Education and Research Building (HERB) + Zoom 👉 Register here: lnkd.in/gQmxX7DZ

"These exciting results open new avenues for developing P. vivax vaccines to combat the global malaria burden and support the path to elimination." - Professor James Beeson 👉https://shorturl.at/hhaNI

We’re delighted to welcome Edwin Sutanto as our newest PhD student. His research focuses on investigating drug resistance in Plasmodium falciparum in Papua, Indonesia using advanced molecular approaches. Read more about his project: acreme.edu.au/welcome-to-a...

Despite a largely subsidised health system, patients and families face other medical, travel and indirect costs when seeking care for febrile illnesses. These costs need consideration when designing malaria control policies🔗 pubmed.ncbi.nlm.nih.gov/41887663/

These awards support ACREME-affiliated PhD students, Postdoctoral Researchers, and Research Assistants/Officers to take part in valuable opportunities such as training workshops, laboratory exchanges, and field-based training. 🔗https://lnkd.in/giYcU-9g

A reminder that the 2026 ACREME Seed Grants are now open 🎉This is a great opportunity to secure funding for projects aligned with the ACREME research themes. Grants of up to $25K are available. 🔗 acreme.edu.au/grants/seed-...

Are you submitting a grant application soon? 🤔 ACREME's Professional Development Scheme includes Grant Application Support, a dedicated initiative designed to give your application the best possible chance. 🔗 acreme.edu.au/what-we-do/o...

Congrats to Dr @cassidyseyoum.bsky.social on being appointed the 2026 Annual Meeting Organiser👏 The role will coordinate the planning and delivery of our Annual Meeting, bringing together researchers across our network. Please join us in congratulating Sarah 🙌

Women in malaria-endemic and low-resource settings are disproportionately affected by malaria, yet they remain underrepresented in research leadership and decision-making. Learn more about how ACREME is recognising and supporting women in malaria research: 🦟 acreme.edu.au/internationa... #IWD2026

Join us for the Developing New Vaccines Symposium 2026 on Tuesday 24 March in Melbourne. A one-day event bringing together leading researchers and partners to explore the latest advances in vaccine discovery and development.🎟️ events.humanitix.com/developing-n...

ACREME was proud to see students, Kaitlin Pekin, Pailene Lim and Janani Karunarathne contribute to the 16th Victorian Infection and Immunity Network Lorne Infection and Immunity Conference in February 👏 @theviin.bsky.social @burnetinstitute.bsky.social @wehi-research.bsky.social

This study aims to assess health system needs for malaria elimination, identify national-level barriers to effective implementation, and provide recommendations for policymakers to strengthen strategies through a health system perspective.🔗https://shorturl.at/lz2h0

Our 2026 Travel Grants are officially open ✈️ 🧳 These awards are designed to support ACREME affiliated PhD students, Postdoctoral Researchers and Research Assistants/Officers to participate in training, lab exchanges, and field-based training. 🔗 acreme.edu.au/grants/trave...

MALARIA MILESTONE | New research published today in The Lancet Infectious Diseases, has confirmed the safety & effectiveness of high-dose primaquine & single-dose tafenoquine in G6PD-normal patients in treating P. vivax #malaria. Read more: tinyurl.com/mw7edaup @kthriemer.bsky.social

We’re excited to announce the launch of the 2026 Seed Grants 🎉 The program offers competitive research funding for pilot projects that fall within the three key research themes of ACREME MASTER-MAP. 🔗https://acreme.edu.au/grants/seed-grant/

We’re seeking an enthusiastic Early or Mid-Career Research Fellow to Chair the 2026 Annual Meeting Committee and contribute to ACREME Investigator Meetings 🗯️🌐 Applications close Friday 27 February. Apply now and help shape 2026: 🔗https://acreme.edu.au/what-we-do/opportunities/

This research aims to assess the effectiveness and safety of these new treatment options. 🔗 www.thelancet.com/journals/lan... #Malaria #MalariaElimination #EFFORTTrial

We’re pleased to announce the launch of our Regional Hub Travel and Training Grants for 2026, supporting collaboration, skills development, and research impact across our regional hubs.👉 acreme.edu.au/grants/trave... #ResearchFunding #GlobalHealth #Malaria #EndMalaria #AsiaPacific

These results highlight the urgent need for climate-resilient malaria control strategies and robust emergency response systems to safeguard progress towards malaria eradication. 🔗 www.nature.com/articles/s41...

This study shows that key parts of this system are shared across multiple malaria species and assemble in a similar way. Research also found that antibodies targeting this complex can block parasite invasion across species. www.nature.com/articles/s41...

We are proud to showcase our members who will be presenting their research at the 16th Lorne Infection and Immunity Conference 🔗 www.lorneinfectionimmunity.org

Burnet researchers Professor James Beeson, Dr Adam Thomas and Dr Herbert Opi have received the prestigious Grand Challenges Grant. The grant will support next-generation mRNA vaccine development for malaria control and elimination. Read more: www.burnet.edu.au/news/develop...

This research presents a mathematical model of RBC dynamics in response to malaria, which includes the spleen as an explicit compartment. 🔗 journals.plos.org/ploscompbiol... #Malaria #MalariaElimination

"Next-gen malaria vaccines have the potential to provide greater impact in preventing illness and death over the currently available vaccines..." @path.org www.path.org/our-impact/a...

Congrats to @rhea-longley.bsky.social on receiving NHMRC e-Asia 2025 funding. This work will apply serological markers to detect hidden Plasmodium vivax infections, strengthening both surveillance and intervention efforts 🎉👏 🔗 www.nhmrc.gov.au/about-us/new...

This study investigates the use of a geostatistical model to analyse routinely collected surveillance data and identify high-risk villages in Hpapun Township, Myanmar.🔗 www.nature.com/articles/s41... @julieasimpson50.bsky.social @devinefy.bsky.social

This year's @who.int World Malaria Report highlights the growing threat of antimalarial drug resistance. We are tackling this by tracking and targeting resistance, blocking transmission, and ensuring safe, effective treatments to drive malaria elimination.👉 lnkd.in/emPdsv8j

🌟We are delighted to celebrate Prof James Beeson and Dr Stephen Scally WEHI on receiving a prestigious award from the Gates Foundation’s Global Grand Challenges initiative. 🌟 #Malaria #MalariaElimination #GlobalHealth #Funding #GatesFoundation #Vaccines

We are seeking a motivated and enthusiastic individual to chair our 2026 Annual Meeting Committee and actively participate in ACREME Investigator Meetings. 🔗 acreme.edu.au/what-we-do/o... #ECR #MCR #ResearchFellow #Funding #Malaria #MalariaElimination

Although the recent introduction of 2 malaria vaccines offers promise, the efficacy and duration of protection are suboptimal, particularly in populations with the highest malaria burdens. Additional strategies are urgently needed to enhance the efficacy 🔗https://shorturl.at/GoGrK

Dr Win Htike, who will be presenting his work “Geospatial joint modelling of vector and parasite serology to microstratify malaria transmission” at the Joint International Tropical Medicine Meeting 2025 on Thursday, 4 December. 🔗https://www.jitmm.com/Home/displayContent?cpID=18 🎉

Our "webinars" page is currently offline as we prepare for an exciting relaunch in early 2026. With more than six years of insightful sessions and expert presentations, there is a wealth of valuable content we’re looking forward to making accessible again soon🌐 acreme.edu.au

A new analysis highlights a promising avenue: intermittent preventive treatment with sulphadoxine–pyrimethamine (IPTp-SP). 🔗 www.thelancet.com/journals/lan...

NMCPs have requested these data to inform decisions regarding national antimalarial policies. This manuscript aims to describe the automated process of generating these reports and highlight their role for policy makers. 🔗 malariajournal.biomedcentral.com/articles/10.... 👏 A collective achievement

Each endemic country implementing the malaria elimination programme should reevaluate, refine, improve & strengthen the ongoing strategy which is fit-for-purpose of the national health system capacity considering the global and regional evidence. 🔗https://bmjpublichealth.bmj.com/content/3/2/e001180

A national dissemination meeting was held by Aga Khan Uni and @menziesresearch.bsky.social to review study results and explore implications for radical cure policy and implementation in Pakistan. Read the meeting report: malariajournal.biomedcentral.com/articles/10....

Join us for our final webinar of the year with Dr Pyae Linn Aung on Thursday, 20 November at 2:00 pm: “Hidden Malaria Transmission among Myanmar Migrants in Thailand.” 🔗 events.humanitix.com/acreme-webin... #Malaria #GlobalHealth #Migrants #MigrantHealth #VectorControl

This study aimed to assess how this 1-3-7 malaria RASR strategy was implemented to understand how it may be optimised to achieve national malaria elimination goals. idpjournal.biomedcentral.com/articles/10....

ACREME was proud to sponsor the @MiM_Melbourne 2025 Conference It was wonderful to see so many ACREME members actively participating. 📸 : Adam Thomas Win Htike Win Han Oo Ellen Kearney Dr Kirsty McCann Alex Harris

The resulting data include malaria prevalence, incidence, mortality, and entomological timeseries; and a novel assembly of qualitative descriptions of malaria seasonality extracted from published literature.🔗 lnkd.in/gr-qZ_Rv

Our data reveal further complexity amongst human Tfh cells, and highlight two distinct subsets associated with antibody-mediated immunity to #malaria. 🔗 insight.jci.org/articles/vie...

Join Dr Aung Pyae Phyo from MORU on Thurs 20 Nov 2pm AEDT for 'Tafenoquine for vivax malaria elimination' 🔗https://shorturl.at/u8bQ8 This presentation shares early insights from a tafenoquine mass drug administration (MDA) pilot in a high-burden P. vivax setting on the Myanmar–Thailand border.

The ACREME Master-MAP team hosted their first in-person Annual Meeting on 13–14 October at Deakin Downtown, Melbourne, bringing together over 70 participants from across Australia. Read more🔗 acreme.edu.au/acreme-annua...

Shorter, more effective treatment options for P. vivax malaria, including 7-day-high-dose primaquine and single-dose tafenoquine, are available and now included in global recommendations. 🔗 malariajournal.biomedcentral.com/articles/10....

In malaria, severe disease risk increases with age in non-immune individuals. Malaria severity is in part driven by inflammation, but mechanisms contributing to age-dependent disease risk are incompletely understood. Read the findings🔗 www.nature.com/articles/s41...